Your browser doesn't support javascript.
loading
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
Raman, Sudha R; Man, Kenneth K C; Bahmanyar, Shahram; Berard, Anick; Bilder, Scott; Boukhris, Takoua; Bushnell, Greta; Crystal, Stephen; Furu, Kari; KaoYang, Yea-Huei; Karlstad, Øystein; Kieler, Helle; Kubota, Kiyoshi; Lai, Edward Chia-Cheng; Martikainen, Jaana E; Maura, Géric; Moore, Nicholas; Montero, Dolores; Nakamura, Hidefumi; Neumann, Anke; Pate, Virginia; Pottegård, Anton; Pratt, Nicole L; Roughead, Elizabeth E; Macias Saint-Gerons, Diego; Stürmer, Til; Su, Chien-Chou; Zoega, Helga; Sturkenbroom, Miriam C J M; Chan, Esther W; Coghill, David; Ip, Patrick; Wong, Ian C K.
Afiliação
  • Raman SR; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
  • Man KKC; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
  • Bahmanyar S; Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, Stockholm, Sweden.
  • Berard A; Faculty of Pharmacy, University of Montreal, and CHU Ste-Justine Research Center, Montreal, Quebec, Canada.
  • Bilder S; Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA.
  • Boukhris T; Faculty of Pharmacy, University of Montreal, and CHU Ste-Justine Research Center, Montreal, Quebec, Canada.
  • Bushnell G; Department of Epidemiology, University of North Carolina, Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
  • Crystal S; Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA.
  • Furu K; Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway.
  • KaoYang YH; School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.
  • Karlstad Ø; Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Kieler H; Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Kubota K; Drug Safety Research Unit, Tokyo, Japan.
  • Lai EC; School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan; Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.
  • Martikainen JE; Research Unit, Social Insurance Institution, Helsinki, Finland.
  • Maura G; Department of Studies in Public Health, French National Health Insurance, Paris, France.
  • Moore N; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.
  • Montero D; Spanish Agency for Medicines and Medical Devices, Madrid, Spain.
  • Nakamura H; Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
  • Neumann A; Department of Studies in Public Health, French National Health Insurance, Paris, France.
  • Pate V; Department of Epidemiology, University of North Carolina, Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
  • Pottegård A; Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.
  • Pratt NL; Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
  • Roughead EE; Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
  • Macias Saint-Gerons D; Spanish Agency for Medicines and Medical Devices, Madrid, Spain; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Valencia, Spain.
  • Stürmer T; Department of Epidemiology, University of North Carolina, Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.
  • Su CC; School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan.
  • Zoega H; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Medicines Policy Research Unit, Centre for Big Data Research in Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Sturkenbroom MCJM; Julius Global Health, University Medical Center Utrecht, Utrecht, Netherlands.
  • Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Coghill D; Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.
  • Ip P; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: patricip@hku.hk.
  • Wong ICK; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Lancet Psychiatry ; 5(10): 824-835, 2018 10.
Article em En | MEDLINE | ID: mdl-30220514
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Padrões de Prática Médica / Estimulantes do Sistema Nervoso Central / Metilfenidato Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Asia / Europa / Oceania Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Padrões de Prática Médica / Estimulantes do Sistema Nervoso Central / Metilfenidato Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Asia / Europa / Oceania Idioma: En Ano de publicação: 2018 Tipo de documento: Article